Hurdles to the introduction of new therapies for immune-mediated kidney diseases
Nature Reviews Nephrology 12, 205 (2016).
doi:10.1038/nrneph.2015.206
Authors: Hans-Joachim Anders, David R. W. Jayne & Brad H. Rovin
Innovative immunotherapies continue to markedly benefit many disciplines in clinical medicine but disappointingly, these benefits have not translated to the treatment of kidney diseases despite encouraging findings from preclinical models of kidney dysfunction. This lack of progress in nephrology might relate to the unique biology
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Hans-Joachim AndersDavid R. W. JayneBrad H. Rovin Tags: Review Source Type: research